Physician profile
Kristopher Bartee
NPI 1548633852
$1,389.29
in general payments reported to CMS, 2019-2025
8 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $326 · 2023: $313 · 2024: $143 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812 · Education: $99.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $812.38 |
| Education | $99.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $557.86 | 2021-2025 | Dupixent |
| Optinose US, INC. | $303.03 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $241.32 | 2022-2025 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $196.34 | 2023-2024 | Nucala, Arexvy |
| Amgen INC. | $44.65 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $20.90 | 2025 | Neffy |
| Covis Pharma Gmbh | $12.75 | 2023 | |
| Genzyme Corporation | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Bartee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.